Latest Insider Transactions at Entrada Therapeutics, Inc. (TRDA)
This section provides a real-time view of insider transactions for Entrada Therapeutics, Inc. (TRDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Entrada Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Entrada Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 02
2021
|
Kush Parmar Director |
BUY
Conversion of derivative security
|
Indirect |
3,827,224
+32.12%
|
-
|
|
Nov 02
2021
|
Todd Foley Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+2.21%
|
$2,000,000
$20.0 P/Share
|
|
Nov 02
2021
|
Todd Foley Director |
BUY
Conversion of derivative security
|
Indirect |
4,325,784
+30.26%
|
-
|
|
Nov 02
2021
|
Mpm Bio Ventures 2014, L.P. |
BUY
Open market or private purchase
|
Indirect |
100,000
+2.21%
|
$2,000,000
$20.0 P/Share
|
|
Nov 02
2021
|
Mpm Bio Ventures 2014, L.P. |
BUY
Conversion of derivative security
|
Indirect |
4,325,784
+30.26%
|
-
|
|
Nov 02
2021
|
Mpm Bioventures 2018, L.P. |
BUY
Open market or private purchase
|
Indirect |
100,000
+2.21%
|
$2,000,000
$20.0 P/Share
|
|
Nov 02
2021
|
Mpm Bioventures 2018, L.P. |
BUY
Conversion of derivative security
|
Indirect |
4,325,784
+30.26%
|
-
|
|
Nov 02
2021
|
Redmile Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+33.85%
|
$20,000,000
$20.0 P/Share
|
|
Nov 02
2021
|
Redmile Group, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
954,420
+50.0%
|
-
|
|
Nov 02
2021
|
5 Am Ventures V, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+18.09%
|
$5,000,000
$20.0 P/Share
|
|
Nov 02
2021
|
5 Am Ventures V, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,827,224
+32.12%
|
-
|
|
Nov 02
2021
|
Roche Holding LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,813,525
+30.08%
|
-
|